ADVANCED PLEURAL MALIGNANT MESOTHELIOMA
Clinical trials for ADVANCED PLEURAL MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PLEURAL MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for ADVANCED PLEURAL MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called BAY 1895344 combined with standard chemotherapy (cisplatin, with or without gemcitabine) in people with advanced solid tumors, especially bladder cancer. The main goals are to find the safest dose and understand side effects. About 7…
Matched conditions: ADVANCED PLEURAL MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:34 UTC
-
Experimental combo aims to outsmart resistant cancers
Disease control OngoingThis study tests whether adding the experimental drug TRC102 to standard chemotherapy (cisplatin and pemetrexed) can shrink tumors or slow cancer growth in people with advanced solid tumors or mesothelioma that have not responded to prior treatments. About 30 adults will take par…
Matched conditions: ADVANCED PLEURAL MALIGNANT MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:33 UTC